Bio Deeptech Innovation: Combining Infrastructure and Capital(venturesquare.net)
Writing language: KoreanRead in the original language
Plain summary
- SNS Lab and MYSC have signed an agreement linking an 850-pyeong shared laboratory with a 100 billion KRW impact fund.
- For bio deeptech teams that spend hundreds of millions of won solely on equipment and lab space, this means a way to secure both space and funding at once, along with Proof of Concept (PoC) opportunities for expansion into Southeast Asia.
- However, merely gathering under one roof does not guarantee smooth transitions from research to investment and overseas validation.
- Let's watch whether tenant companies actually move on to the next stage.
Have you run into something like this? Tell us in a line or two what you did. You do not need to know the product.